In this free webinar, learn about the role of artificial intelligence (AI) in optimising clinical trial site identification and selection. Attendees will gain insights on transitioning from a state of data overload to one of data driven, informed decision-making. The featured speaker will share expected and unexpected downstream benefits of an AI-enabled site selection strategy.

TORONTO, Ontario, Aug. 2, 2023 /PRNewswire-PRWeb/ — A new webinar has been announced to tackle one of the clinical trial industry’s most pressing challenges: effective and timely patient recruitment through optimal clinical trial site identification and selection.

The session, titled “Advancements in AI for optimal clinical trial site identification: Turning Big Data into actionable intel”, seeks to demystify the potential of artificial intelligence (AI) in identifying ideal clinical trial sites, a vital factor in successful patient recruitment.

The webinar will be guided by an industry expert, Travis Caudill, the Vice President of Feasibility, Site Identification & Clinical Informatics at ICON. Caudill, with his vast experience in clinical trial strategy, global feasibility and site identification, oversees a team of dedicated experts who harness data to support effective decision-making for pharma, biotech and medical device sponsors.

During the webinar, participants can expect to gain a deeper understanding of how to transform a state of data overload into informed, data-driven decision-making. The role of AI in enhancing clinical trial site identification and selection will be examined in-depth. Furthermore, the session will highlight both the expected and unforeseen benefits of employing an AI-enabled site selection strategy.

This invaluable learning opportunity is especially beneficial for professionals in the pharmaceutical, medical device and biotechnology sectors. Roles focusing on site identification and selection, clinical operations, procurement/outsourcing and quality/compliance will find the content particularly insightful.

ICON, a global provider of outsourced development and commercialization services to the pharmaceutical, biotechnology and medical device industries, plays a crucial role in the realization of this initiative. The organization has forged a strategic partnership with Xtalks to deliver this important webinar.

Mark your calendars for the live webinar on Tuesday, August 22, 2023, at 11am EDT (4pm BST/UK) to partake in this timely discussion. The webinar is sure to provide a fresh perspective and pragmatic guidance for clinical trial professionals across the globe.

For more information, or to register for this event, visit Advancements in AI for optimal clinical trial site identification: Turning Big Data into actionable intel.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Pull Quote

Roles focusing on site identification and selection, clinical operations, procurement/outsourcing and quality/compliance will find the content particularly insightful.

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks